BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9846539)

  • 1. Prediction of human oral cancer radiation responsiveness by histone (H3) mRNA in situ hybridization: a preliminary report.
    Donoff RB; Todd R; Elovic A; Gallagher GT; Chou MY; Wong DT
    J Oral Maxillofac Surg; 1998 Dec; 56(12):1410-6. PubMed ID: 9846539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
    Kotelnikov V; Cass L; Coon JS; Spaulding D; Preisler HD
    Clin Cancer Res; 1997 May; 3(5):669-73. PubMed ID: 9815735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
    Nagao T; Ishida Y; Kondo Y
    Mod Pathol; 1996 Feb; 9(2):99-104. PubMed ID: 8657727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3 messenger RNA in situ hybridization correlates with in vivo bromodeoxyuridine labeling of S-phase cells in rat colonic epithelium.
    Konishi H; Steinbach G; Terry NH; Lee JJ; Dubin JA; Glober GA; Fujita K; Spaulding D; Cass L; Hittelman WN
    Cancer Res; 1996 Feb; 56(3):434-7. PubMed ID: 8564947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone gene (H3) expression in chemically transformed oral keratinocytes.
    Wong DT
    Exp Mol Pathol; 1988 Oct; 49(2):206-14. PubMed ID: 2458960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell kinetic study of the endometrium by nonisotopic in situ hybridization for histone H3 messenger RNA and immunohistochemistry for Ki-67 and for estrogen and progesterone receptors.
    Hayama M; Ota H; Toki T; Ishii K; Honda T; Momose M; Nakata R
    Anat Rec; 2002 Apr; 266(4):234-40. PubMed ID: 11920386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone H3 mRNA in situ hybridization for identifying proliferating cells in human pancreas, with special reference to the ductal system.
    Arakura N; Hayama M; Honda T; Matsuzawa K; Akamatsu T; Ota H
    Histochem J; 2001 Mar; 33(3):183-91. PubMed ID: 11508342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive epigenetic analysis using oral rinse samples: a pilot study.
    Kusumoto T; Hamada T; Yamada N; Nagata S; Kanmura Y; Houjou I; Kamikawa Y; Yonezawa S; Sugihara K
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1486-94. PubMed ID: 21821326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying genes related to radiation resistance in oral squamous cell carcinoma cell lines.
    Lee SY; Park HR; Cho NH; Choi YP; Rha SY; Park SW; Kim SH
    Int J Oral Maxillofac Surg; 2013 Feb; 42(2):169-76. PubMed ID: 23196067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
    Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
    Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells.
    Ishigami T; Uzawa K; Higo M; Nomura H; Saito K; Kato Y; Nakashima D; Shiiba M; Bukawa H; Yokoe H; Kawata T; Ito H; Tanzawa H
    Int J Cancer; 2007 May; 120(10):2262-70. PubMed ID: 17290400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of cell proliferation during 9,10-dimethyl-1,2-benzanthracene-induced hamster tongue carcinogenesis by means of histone H3 mRNA in situ hybridization.
    Sakamoto R; Nitta T; Kamikawa Y; Sugihara K; Hasui K; Tsuyama S; Murata F
    Med Electron Microsc; 2004 Mar; 37(1):52-61. PubMed ID: 15057605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intracellular H3 messenger RNA as a marker to determine the proliferation pattern of normal and 7,12-dimethylbenz[a]anthracene-transformed hamster oral epithelium.
    Wong DT; Chou MY; Chang LC; Gallagher GT
    Cancer Res; 1990 Aug; 50(16):5107-11. PubMed ID: 2116225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
    Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
    Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-cycle-dependent gene expression studied by two-colour fluorescent detection of a mRNA and histone mRNA.
    Dirks RW; Raap AK
    Histochem Cell Biol; 1995 Nov; 104(5):391-5. PubMed ID: 8574889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression.
    Shindoh M; Chiba I; Yasuda M; Saito T; Funaoka K; Kohgo T; Amemiya A; Sawada Y; Fujinaga K
    Cancer; 1995 Nov; 76(9):1513-21. PubMed ID: 8635051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug inhibition increases radiosensitivity of oral squamous cell carcinoma cells by upregulating PUMA.
    Jiang F; Zhou L; Wei C; Zhao W; Yu D
    Int J Oncol; 2016 Aug; 49(2):709-19. PubMed ID: 27277529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferative activity estimated by histone H2B mRNA level correlates with cytogenetic damage induced by radiation in human glioblastoma cell lines.
    Slowinski J; Mazurek U; Bierzynska-Macyszyn G; Widel M; Latocha M; Glogowska-Ligus J; Stomal M; Mrowka R
    J Neurooncol; 2005 Feb; 71(3):237-43. PubMed ID: 15735911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
    Sun HB; Zheng HY; Yan X
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and p53 are associated with effect of preoperative radiation in oral squamous cell carcinomas.
    Shintani S; Mihara M; Nakahara Y; Terakado N; Yoshihama Y; Kiyota A; Ueyama Y; Matsumura T
    Cancer Lett; 2000 Jun; 154(1):71-7. PubMed ID: 10799741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.